Prevalence of Depression in Patients with Diabetic Retinopathy
Authors: not saved
Abstract:
Background and Objective:Diabetic retinopathy is one of the most important and debilitating complications of diabetes with an increasing prevalence in most countries. It has a dramatic effect on peoplechr('39')s quality of life and increases the symptoms of anxiety and depression in patients with diabetes. Therefore, the present study aimed to determine the prevalence of depression in patients with diabetic retinopathy. Materials and Methods:This descriptive/ cross-sectional study was conducted on 245 patients with retinopathy referred to the ophthalmology clinic of Farshchian Hospital in Hamadan during 2019- 2020. They were selected via available and consecutive sampling method and were evaluated for depression with the 21-item Beck questionnaire. Data were analyzed in SPSS software (version 16) at a 95% confidence level. Results:The mean scores of patientschr('39') age and duration of diabetes were reported as 54.47± 8.5 and 8.5 ± 4.15 years, respectively. In terms of gender, the majority of participants (58.7%) were female. The prevalence of depression in patients with diabetic retinopathy was obtained at 49.8% and in proliferative and non-proliferative retinopathy were 68.2% and 43%, respectively (P<0.001). The prevalence rates of depression in men and women were reported as 45.9% and 51.5% (P=0.428). Moreover, in patients treated with insulin and without insulin, the prevalence rates of depression were obtained at 50.4% and 49.2% (P=0.846). The correlation coefficients of depressive disorder with age and duration of diabetes were calculated at 0.123 (P=0.054) and 0.369 (P<0.001), respectively. Conclusion:Depression is one of the most serious problems in patients with diabetic retinopathy. As evidenced by the results of the present study, the prevalence ofdepression is significantly correlated with the severity of retinopathy and duration of diabetes.
similar resources
Serum Levels of Interferon-Gamma in Patients with Diabetic Retinopathy
Background: In recent years, numerous studies have addressed the role of other factors, especially the immune system, on developing diabetic retinopathy. Given the role of interferons in regulating immune system activities, the present study was conducted to investigate serum levels of interferon-gamma in patients with diabetic retinopathy. Materials and Methods: The present research was condu...
full textQuality of Life in Patients with Diabetic Retinopathy
Introduction: Diabetic retinopathy is a major cause of blindness and a fundamental cause of disability in diabetic patients in the world. Investigation about the quality of life in these patients can help plan for taking nursing measures to prevent or control the disease and improve patients’ quality of life. Objective: This study aimed to determine the quality of life in patient...
full textAssociation of CXCL12 and CXCR4 Genes Polymorphism with Proliferative Diabetic Retinopathy in Diabetic Patients
Introduction: Patients with diabetes are prone to develop complications related to the retina. So far, several genes have been reported in connection with the progression of retinopathy, and a group of these genes is genes involved in angiogenesis. CXCL12 and CXCR4 genes are among the most important genes in this path, which have been less studied and investigated. The aim of this study was to ...
full textPrevalence of risk factors in diabetic patients with oral complications
Introduction: Diabetes results in several oral complications. Many last studies about risk factors effect on oral manifestations has been controversial. Therefore, according to its importance, the purpose of this study was to evaluate the risk factors in diabetic patients with oral complications. Materials and Methods: In this cross-sectional study 257 subjects out of 600 diabetic patients were...
full textMy Resources
Journal title
volume 27 issue 4
pages 0- 0
publication date 2021-03
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023